Myocardial perfusion scans: Projected population cancer risks from current levels of use in the United States

Circulation

Volumn 122, Issue 23, 2010, Pages 2403-2410

  De Gonzalez, Amy Berrington ^a   Kim, Kwang Pyo ^b   Smith Bindman, Rebecca ^c   McAreavey, Dorothea ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Kyung Hee University   (South Korea)

^c UNIVERSITY OF SAN FRANCISCO   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

cancer risks; computed tomography; nuclear medicine; perfusion; radioisotopes

Indexed keywords

AMMONIA; TECHNETIUM 99M; THALLIUM 201;

ADULT; ARTICLE; CANCER RISK; FEMALE; HEART MUSCLE PERFUSION; HUMAN; LIFE EXPECTANCY; MALE; MONTE CARLO METHOD; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; RISK BENEFIT ANALYSIS; UNITED STATES;

AGED; FEMALE; FORECASTING; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RISK FACTORS; UNITED STATES;

EID: 78650709079     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.941625     Document Type: Article

References (47)

1. -2008 Nuclear Medicine: Market Summary Report. Des Plains, Ill: IMV Medical Information Division 2008: IV19-IV30.
2. Mettler FA Jr, Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology. 2008; 248:254-263.
3. Mettler FA Jr, Thomadsen BR, Bhargavan M, Gilley DB, Gray JE, Lipoti JA, McCrohan J, Yoshizumi TT, Mahesh M. Medical radiation exposure in the U.S. in 2006: preliminary results. Health Phys. 2008; 95:502-507.
4. Fazel R, Krumholz HM, Wang Y, Ross JS, Chen J, Ting HH, Shah ND, Nasir K, Einstein AJ, Nallamothu BK. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med. 2009;361: 849-857.
5. Berrington de Gonzalez A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, Land C. Projected number of future cancers related to CT scan use in the US in 2007. Arch Intern Med. 2009;169:2071-2077.
6. Smith-Bindman R, Lipson J, Marcus R, Kim KP, Mahesh M, Gould R, Berrington de González A, Miglioretti DL. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med. 2009;169: 2078-2086.
7. Henzlova MJ, Cerqueira MD, Hansen CL, Taillefer R, Yao SS. American Society of Nuclear Cardiology Imaging guidelines for nuclear cardiology procedures: stress protocols and tracers. 2009. Available at: http://www.asnc.org/section-73.cfm. Accessed April 2009.
8. Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation, National Research Council of the National Academies. Health Risks From Exposure To Low Levels of Ionizing Radiation: BEIR VII Phase 2. Washington, DC: National Academies Press; 2006.
9. International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals. Ann ICRP. 1998;28:1-123. ICRP publication 80.
10. International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals. Ann ICRP. 1987;18:1-4. ICRP publication 53.
11. Dilsizian V, Bacharach SLB, Beanlands RS, Bergmann SR, Delbeke DG, Gropler RJ, Knuuti J, Schelbert HR, Travin MI. ASNC imaging guidelines for nuclear medicine imaging PET myocardial perfusion and metabolism clinical imaging 2009. Available at: http://www.asnc.org/section-73.cfm.
12. Stamm G, Nagel HD. CT-Expo: a novel program for dose evaluation in CT. Rofo. 2002;174:1570-1576.
13. ImPACT. ImPACT CT Patient Dosimetry Calculator: Version 0.99x. London, UK: Imaging Performance Assessment of CT Scanners 2006.
14. Jones DG, Shrimpton PC. Survey of CT Practice in the UK, Part 3: Normalized Organ Doses Calculated Using Monte Carlo Techniques. Chilton, UK: National Radiological Protection Board; 1991. NRPB-R250.
15. Jones DG, Shrimpton PC. Normalized Organ Doses for X-Ray Computed Tomography Calculated Using Monte Carlo Techniques. Chilton, UK: National Radiological Protection Board; 1993. NRPB-SR250.
16. Zankl M, Panzer W, Drexler G. The Calculation of Dose From External Photon Exposures Using Reference Human Phantoms and Monte Carlo Methods, Part VI: Organ Doses From Computed Tomographic Examinations. Neuherberg, Germany: GSF-Forschungszentrum fur Umwelt und Gesundtheit, Institut fur Strahlenschutz; 1991. GSF-Bericht 30/91.
17. -2008 PET Benchmark Report. Des Plains, Ill: IMV Medical Information Division 2009.
18. National Council on Radiation Protection and Measurements (NRCP). Ionizing Radiation Exposure of the Population of the United States. Bethesda, Md: NCRP 2009. Report No. 60.
19. Marwick TH, Shaw LJ, Lauer MS, Kesler K, Hachamovitch R, Heller GV, Travin MI, Borges-Neto S, Berman DS, Miller DD; Economics of Noninvasive Diagnosis (END) Study Group. The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Am J Med. 1999;106:172-178.
20. Thomas D, Darby S, Fagnani F, Hubert P, Vaeth M, Weiss K. Definition and estimation of lifetime detriment from radiation exposures: principles and methods. Health Phys. 1992;63:259-272.
21. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 2007;168:1-64.
22. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995; 141:259-277.
23. Preston DL, Mattsson A, Holmberg E, Shore R, Hildreth NG, Boice JD Jr. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res. 2002;158:220-235.
24. Analytica 4.1 [computer program]. Los Gatos, Calif: Lumina Decisions Systems Inc 2008.
25. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004;328:1519.
26. Einstein AJ. Radiation risk from coronary artery disease imaging: how do different diagnostic tests compare Heart. 2008;94:1519-1521.
27. Strauss HW, Miller DD, Wittry MD, Cerqueira MD, Garcia EV, Iskandrian AS, Schelbert HR, Wackers FJ, Balon HR, Lang O, Machac J. Procedure guideline for myocardial perfusion imaging 3.3. J Nucl Med Technol. 2008;36:155-161.
28. Hesse B, Tägil K, Cuocolo A, Anagnostopoulos C, Bardiés M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, McKiddie F, O'Connor M, Prvulovich E, Underwood R, van Eck-Smit B; EANM/ESC Group. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging. 2005;32:855-897.
29. Robinson CN, Van Aswegen A, Julious SA, Nunan TO, Thomson WH, Tindale WB, Tout DA, Underwood SR. The relationship between administered radiopharmaceutical activity in myocardial perfusion scintigraphy and imaging outcome. Eur J Nucl Med Mol Imaging. 2008;35:329-335.
30. Van Train KF, Maddahi J, Berman DS, Kiat H, Areeda J, Prigent F, Friedman J. Quantitative analysis of tomographic stress thallium-201 myocardial scintigrams: a multicenter trial. J Nucl Med. 1990;31: 1168-1179.
31. Berman DS, Kiat H, Friedman JD, Kiat H, Areeda J, Prigent F, Friedman J. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol. 1993;22: 1455-1464.
32. Schuleri KH, George RT, Lardo AC. Applications of cardiac multide-tector CT beyond coronary angiography. Nat Rev Cardiol. 2009;6: 699-710.
33. Gambhir SS, Berman DS, Ziffer J, Nagler M, Sandler M, Patton J, Hutton B, Sharir T, Haim SB, Haim SB. A novel high-sensitivity rapid-acquisition single-photon cardiac imaging camera. J Nucl Med. 2009;50: 635-643.
34. Land CE. Estimating cancer risks from low doses of ionizing radiation. Science. 1980;209:1197-1203.
35. Little MP, Wakeford R, Tawn EJ, Bouffler SD, Berrington de Gonzalez A. Risks associated with low doses and low dose rates of ionizing radiation: why linearity may be (almost) the best we can do. Radiology. 2009;251:6-12.
36. Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, Howe G, Kaldor J, Muirhead CR, Schubauer-Berigan M, Yoshimura T, Bermann F, Cowper G, Fix J, Hacker C, Heinmiller B, Marshall M, Thierry-Chef I, Utterback D, Ahn YO, Amoros E, Ashmore P, Auvinen A, Bae JM, Solano JB, Biau A, Combalot E, Deboodt P, Diez Sacristan A, Eklof M, Engels H, Engholm G, Gulis G, Habib R, Holan K, Hyvonen H, Kerekes A, Kurtinaitis J, Malker H, Martuzzi M, Mastauskas A, Monnet A, Moser M, Pearce MS, Richardson DB, Rodriguez-Artalejo F, Rogel A, Tardy H, Telle-Lamberton M, Turai I, Usel M, Veress K. The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry: estimates of radiation-related cancer risk. Radiat Res. 2007;167: 396-416. (Pubitemid 351292972)
37. Pierce DA, Preston DL. Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res. 2000;154:178-186.
38. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Sources and Effects of Ionizing Radiation. New York, NY: United Nations 2006.
39. Low-dose extrapolation of radiation related cancer risk. Ann ICRP. 2005; 35:1-142. ICRP publication 99.
40. Tubiana M, Feinendegen LF, Yang C, Kaminski JM. The linear no-threshold relationship is inconsistent with radiation biologic and experimental data. Radiology. 2009;251:13-22.
41. Iskander S, Iskandrian AE. Prognostic utility of myocardial viability assessment. Am J Cardiol. 1999;83:696-702, A7.
42. Hachamovitch R, Kang X, Amanullah AM, Abidov A, Hayes SW, Friedman JD, Cohen I, Thomson LE, Germano G, Berman DS. Prognostic implications of myocardial perfusion single-photon emission computed tomography in the elderly. Circulation. 2009;120:2197-2206.
43. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, Friedman JD, Germano G, Van Train K, Diamond GA. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m ses-tamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol. 1995;26:639-647.
44. Thomas GS, Miyamoto MI, Morello AP, Majmundar H, Thomas JJ, Sampson CH, Hachamovitch R, Shaw LJ. Technetium-99m sestamibi myocardial perfusion imaging predicts clinical outcome in the community outpatient setting. J Am Coll Cardiol. 2004;43:213-223.
45. Lucas FL, DeLorenzo MA, Siewers AE, Wennberg DE. Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993-2001. Circulation. 2006;113:374-379.
46. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA, Pohost GM, Williams KA. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine; endorsed by the American College of Emergency Physicians. J Am Coll Cardiol. 2009;53:2201-2229.
47. Hendel RC, Cerqueira M, Douglas PS, Caruth KC, Allen JM, Jensen NC, Pan W, Brindis R, Wolk MA. Multicenter assessment of the use of single-photon emission computed tomography myocardial perfusion imaging with appropriateness criteria. J Am Coll Cardiol. 2010;55: 156-162.